Scarica l'app Stockscreener
38.85
1.60%
0.61
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IMVT Giù?
Forum
Previsione
Immunovant Inc Borsa (IMVT) Ultime notizie
Insider Sell: Melanie Gloria Sells 17,714 Shares of Immunovant I - GuruFocus
Avoiding Lag: Real-Time Signals in (IMVT) Movement - Stock Traders Daily
Immunovant CTO Jay Stout sells $1.53m in company stock By Investing.com - Investing.com Nigeria
Form 4 Immunovant Inc For: 26 June By Investing.com - Investing.com Australia
Immunovant chief legal officer sells $682,886 in stock - Investing.com
Immunovant (IMVT) CFO exercises options, sells 10,000 shares at ~$38 average - Stock Titan
Immunovant COO Melanie Gloria sells $678k in company stock By Investing.com - Investing.com South Africa
Immunovant director Atul Pande sells $57,015 in stock By Investing.com - Investing.com Canada
Immunovant (IMVT) COO sells 17,714 shares, keeps 224,393 stake - Stock Titan
Immunovant (IMVT) CTO Jay S. Stout sells 40,000 shares in open-market trades - Stock Titan
Immunovant (IMVT) Chief Legal Officer sells 17,824 shares after option exercise - Stock Titan
Immunovant (IMVT) director sells 1,500 shares after option exercise - Stock Titan
Form 144 IMMUNOVANT For: 26 June By Investing.com - Investing.com India
Insider Sale: President & Immunovant CEO of $ROIV Sells 46,234 Shares - Quiver Quantitative
IMVT (NASDAQ) Form 144 lists multiple vested restricted stock blocks, 40,000 header - Stock Titan
IMVT (NASDAQ: IMVT) files Form 144 for 17,824-share sale after option exercise - Stock Titan
[144] Immunovant, Inc. SEC Filing - Stock Titan
Immunovant Inc Actuals & Estimates (NASDAQ:IMVT) - TradingView
Price to sales forward of Immunovant, Inc. – NASDAQ:IMVT - TradingView
IMVT Forecast — Price Target — Prediction for 2027 - TradingView
Immunovant (IMVT) up 3.6% since last earnings report: Can it continue? - MSN
Immunovant (IMVT) CLO mandated share sale to cover RSU tax withholding - Stock Titan
Immunovant stock hits 52-week high at 36.39 USD By Investing.com - Investing.com Australia
Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight - GlobeNewswire Inc.
Immunovant stock hits 52-week high at 36.39 USD - Investing.com
Immunovant Stockweekly view after recent volatility - Ad-hoc-news.de
Immunovant stock gains 12.4% in a month: What's driving it? - MSN
Immunovant (IMVT) Up 3.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Immunovant Inc (IMVT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Immunovant Inc (IMVT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Immunovant Inc (IMVT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Immunovant Inc (IMVT) Institutional Confidence - TradingKey
Immunovant Inc (IMVT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Immunovant Inc (IMVT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Immunovant Inc (IMVT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Immunovant Inc (IMVT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Immunovant Inc (IMVT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IMVT's Q4 loss wider than expected, stock up 35% on strong study data - MSN
Immunovant (IMVT) director trades 1,500 shares under 10b5-1 plan - Stock Titan
Discipline and Rules-Based Execution in IMVT Response - Stock Traders Daily
IMVT (NASDAQ: IMVT) files Form 144 reporting 6,000-share option exercise sale - Stock Titan
Immunovant Q4 earnings call highlights - MSN
Immunovant Stock Gains 12.4% in a Month: What's Driving It? - The Globe and Mail
Immunovant Q4 2026 earnings preview - MSN
Immunovant Inc stock (US45258Q1058): shares trade around mid-30 USD ahead of next catalysts - AD HOC NEWS
Assessing Immunovant (IMVT) Valuation After Strong IMVT 1402 Phase 2 Rheumatoid Arthritis Trial Commentary - Yahoo Finance
Behavioral Patterns of IMVT and Institutional Flows - Stock Traders Daily
IMVT Technical Analysis & Stock Price Forecast - Intellectia AI
H.C. Wainwright Raises Price Target on Immunovant (IMVT) Following Positive Rheumatoid Arthritis Trial Data - Insider Monkey
13 Best Short Squeeze Stocks to Invest In - Insider Monkey
A Quick Look at Today's Ratings for Immunovant(IMVT.US), With a Forecast Between $40 to $45 - Moomoo
Immunovant(IMVT.US) Director Sells US$7.44 Million in Common Stock - Moomoo
1.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):